Literature DB >> 17683792

Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.

Francesco Fera1, Giuseppe Nicoletti, Antonio Cerasa, Nelide Romeo, Olivier Gallo, Maria C Gioia, Gennarina Arabia, Pierfrancesco Pugliese, Mario Zappia, Aldo Quattrone.   

Abstract

The dopaminergic modulation of prefrontal function in Parkinson's disease (PD) has been consistently demonstrated. There is evidence that the effects of pharmacological manipulations on cognitive performances are described by an "Inverted-U" shaped curve. Neuroimaging studies performed before and after an overnight withdrawal from therapy showed significant differences between drug states, but did not control for the relative impact of the long duration response to levodopa. Here we evaluate the brain response after a complete pharmacological washout by correlating dopaminergic-related changes of this response to changes in performance during cognitive interference. Twelve idiopathic PD patients were studied with functional MRI while performing a modified version of the Stroop task. Patients were scanned twice: (1) following a prolonged washout procedure ("OFF" state) and (2) 90-120 min after the administration of levodopa ("ON" state). Task-related changes of PD patients were compared to those of matched healthy controls. Healthy controls displayed prefrontal and parietal responses that were positively correlated with task accuracy. In the "OFF" state, PD patients showed significant responses in anterior cingulate and pre-supplementary motor area, which are hypothesized to operate at a higher level of basal dopaminergic modulation. Levodopa administration attenuated such responses and enhanced the response of prefrontal cortex (PFC), which was correlated with improved accuracy. Results demonstrate that the behavioral effects of pharmacological manipulations of the dopamine system are highly dependent on the baseline status of PFC. When a true hypodopaminergic state is induced in PD patients, cognitive interference might significantly benefit from the administration of levodopa via an enhanced PFC response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683792     DOI: 10.1016/j.brainresbull.2007.05.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  22 in total

1.  Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients.

Authors:  Roberto Erro; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Marianna Amboni; Katia Longo; Angela Costagliola; Maria Teresa Pellecchia; Roberto Allocca; Anna De Rosa; Giuseppe De Michele; Lucio Santoro; Paolo Barone
Journal:  J Neurol       Date:  2012-02-07       Impact factor: 4.849

2.  Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.

Authors:  Anne-Marie A Wills; Jordan J Elm; Rong Ye; Kelvin L Chou; Sotirios A Parashos; Robert A Hauser; Ivan Bodis-Wollner; Vanessa K Hinson; Chadwick W Christine; Jay S Schneider
Journal:  Parkinsonism Relat Disord       Date:  2016-10-08       Impact factor: 4.891

3.  Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Authors:  Brenda Hanna-Pladdy; Rajesh Pahwa; Kelly E Lyons
Journal:  J Int Neuropsychol Soc       Date:  2015-04-29       Impact factor: 2.892

4.  Stroop test performance in impulsive and non impulsive patients with Parkinson's disease.

Authors:  Atbin Djamshidian; Sean S O'Sullivan; Andrew Lees; Bruno B Averbeck
Journal:  Parkinsonism Relat Disord       Date:  2011-01-17       Impact factor: 4.891

5.  Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.

Authors:  Dorothee Kübler; Henning Schroll; Ralph Buchert; Andrea A Kühn
Journal:  J Neural Transm (Vienna)       Date:  2017-06-22       Impact factor: 3.575

Review 6.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

7.  Inhibitory control training and transcranial direct current stimulation of the pre-supplementary motor area: behavioral gains and transfer effects.

Authors:  Jing Zhou; Bin Xuan
Journal:  Exp Brain Res       Date:  2022-01-27       Impact factor: 1.972

Review 8.  Current role of functional MRI in the diagnosis of movement disorders.

Authors:  Fatta B Nahab; Mark Hallett
Journal:  Neuroimaging Clin N Am       Date:  2010-02       Impact factor: 2.264

9.  Genetic associations with reflexive visual attention in infancy and childhood.

Authors:  Rebecca A Lundwall; James L Dannemiller; H Hill Goldsmith
Journal:  Dev Sci       Date:  2015-11-27

Review 10.  Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  Ther Adv Psychopharmacol       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.